Jean-Francois Laes

Head Of IVD Development EMEA at Veracyte

Jean-Francois Laes has a diverse work experience in the field of diagnostics and biotechnology. Jean-Francois'smost recent role at Veracyte, Inc. as the Head of IVD nCounter Development EMEA involves supervising scientific and technical project teams, overseeing product development for EU and US markets, and providing support to the technical support team. Prior to this, they served as the CSO of the OncoDNA Group, where they developed and validated a CE IVD kit called OncoDEEP. Jean-Francois also held positions as the COO and CTO at OncoDNA, where they led scientific, technological, and R&D programs and oversaw the company's operations and technology development. Before that, their experience includes working at Life Technologies as a Senior Field Application Specialist in Next Generation Sequencing and DNAVision as the Next Generation Sequencing Technology Manager and Microarray Unit Manager. Jean-Francois has also worked at Biovallee as the Microarray Unit team leader and at Institut Jules Bordet as a Team leader, focusing on biostatistical and bioinformatical analyses of microarrays. Overall, Jean-Francois Laes has a strong background in scientific and technical leadership roles within the diagnostic and biotechnology industry.

Jean-Francois Laes has a strong educational background with a focus on genomics, molecular biology, and genetics. Jean-Francois began their academic journey in 1992 at the Université libre de Bruxelles, where they obtained a Bachelor of Science degree in Molecular Biology in 1996. Following this, Laes pursued further studies at the same university and attained a Phd degree in Genomics, Molecular Biology, and Genetics in 2001. In addition to their bachelor's and doctoral degrees, Laes also engaged in a year-long program at the Université du Travail from 2000 to 2001, specializing in Informatics and Database Management. These educational experiences demonstrate Laes' dedication to developing expertise in the fields of genomics, molecular biology, and genetics, as well as their broad interest in informatics and database management.

Links

Previous companies

OncoDNA logo

Timeline

  • Head Of IVD Development EMEA

    November 1, 2023 - present

  • Head Of IVD Ncounter Development EMEA

    April, 2022

View in org chart